Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Pharma giant Gilead Sciences again plays the villain in this story but there’s plenty of blame to go around.
These encouraging results do not apply, however, to people who remain undiagnosed.
It’s been 30 years since the Ryan White CARE Act was signed into law, the result of bi-partisan support. Could that have even happened now?
The AIDS Institute urges leaders to prioritize public health funding amidst the COVID-19 pandemic.
A recent study found that about 7.5% of those who achieved viral suppression on antiretrovirals had viral rebound in a one-year period.
Two HIV researchers discuss their recent books on gay men and HIV-positive women.
A new analysis finds that Obamacare has driven down the proportion of individuals without insurance.
Pharma sets the prices for HIV and hep C drugs very high. What happens to those prices along the supply chain?
Researchers tracked viral suppression rates among those receiving Ryan White–backed HIV care who switched to Medicaid or private insurance.
The announcement of a reinstated Presidential Advisory Council on HIV/AIDS (PACHA) is a cynical ploy. We shouldn’t fall for it.
A group of experts has issued a call to arms, spotlighting missed opportunities for addiction treatment in hospital settings.
Certain subgroups of this population, such as smokers and those with depression, are less likely to have an undetectable viral load.
A recent analysis of transgender men in care for HIV found high rates of poverty and lack of viral suppression.
Puerto Rico’s economic crisis threatens critical progress on HIV.
Lambda Legal fights for LGBT people and everyone living with HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.